Showing results (101-110 of 337) with videos related to
Sort By:
Pageof 34
The American Journal of Cardiology|November 1, 1991
Cholesterol-lowering effects of a 10 mg daily dose of lovastatin in patients with initial total cholesterol levels 200 to 240 mg/dl (5.18 to 6.21 mmol/liter)A Rubinstein, Y Lurie, I Groskop, et al.Postgraduate Medical Journal|January 1, 1982
Bilateral femoral neck fractures as a result of coeliac diseaseA Rubinstein, M Liron, G Bodner, et al.Bioconjugate Chemistry|November 22, 2001
Enhanced biorecognition and internalization of HPMA copolymers containing multiple or multivalent carbohydrate side-chains by human hepatocarcinoma cellsA David, P Kopecková, A Rubinstein, et al.Clinical Rheumatology|January 1, 1986
Hyperlipidemias and rheumatic manifestationsB Fishel, T O Rosenbach, M Yaron, et al.American Journal of Diseases of Children (1960)|March 1, 1987
Thymic hypoplasia associated with isotretinoin embryopathyM Cohen, A Rubinstein, J K Li, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|January 21, 2000
Phosphated crosslinked guar for colon-specific drug delivery. I. Preparation and physicochemical characterizationI Gliko-Kabir, B Yagen, A Penhasi, et al.Annals of the New York Academy of Sciences|January 1, 1990
Isoform-specific cDNAs for human embryonic, neonatal, and slow skeletal myosin heavy chainsH H Stedman, A M Kelly, N A RubinsteinBiomaterials|June 1, 1993
Enzymatic cleavage of disaccharide side groups in insoluble synthetic polymers: a new method for specific delivery of drugs to the colonA Sintov, S Ankol, D P Levy, et al.Pharmaceutical Research|August 4, 1998
Low swelling, crosslinked guar and its potential use as colon-specific drug carrierI Gliko-Kabir, B Yagen, A Penhasi, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|January 21, 2000
Phosphated crosslinked guar for colon-specific drug delivery. II. In vitro and in vivo evaluation in the ratI Gliko-Kabir, B Yagen, M Baluom, et al.Pageof 34